Skip to content
Medical Health Aged Care, Seniors Interest

Son of TV Legend Don Lane on Reducing Risk of Alzheimer’s Disease

Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney 2 mins read

Son of TV legend Don Lane is running his first ever Marathon in this Sunday's Sydney Marathon event, in support of dementia research led by the Centre for Healthy Brain Ageing (CHeBA).

PJ Lane was just 24 years of age when he lost his larger than life father to the disease, and since becoming an Ambassador for CHeBA in 2012 has made it his mission to understand more about the Alzhimer’s and other dementias, which research indicates is triggered not only by genetics but also by lifestyle factors. 

September is World Alzheimer’s month with Alzheimer’s Disease International (ADI) recently releasing this year’s theme focusing on the critical role of risk reduction to stave off, delay or prevent dementia.

There is a growing body of research evidence that shows there are 12 potentially modifiable risk factors – with a key one being physical inactivity. 

Other proven risk factors for dementia include smoking, excessive alcohol consumption, infrequent social contact, head injuries, and conditions including diabetes, hearing loss, depression, obesity, and hypertension – all of which individuals have some control over. 

The remaining risk factors include air pollution and restricted access to early education, which governments are responsible for addressing.

ADI says that up to 40% of projected dementia cases could be delayed or potentially even avoided by addressing just 12 risk factors.

PJ, a former professional basketballer who is currently studying a Masters of High Performance Sport, says that losing his Dad to Alzheimer’s disease has made him to everything in his power to reduce his own risk of the disease.

“I’ve often questioned the genetic component of the disease,” says PJ.

“We’re all getting older,” he says. “Although we can’t change our genes or stop ageing, there are fundamental changes all of us can make to reduce our own risk – and remaining active throughout our lives is important.”

To acknowledge this fact PJ chose to up the ante on his cardiovascular health this year and has been running 7 hours a week in preparation for the 17 September event.

CHeBA’s Co-Directors and world-leaders in the ageing brain, Professor Henry Brodaty and Professor Perminder Sachdev, congratulated PJ on his enormous efforts to advocate for awareness into healthy brain ageing, his personal drive to reduce risk of cognitive decline as well and his tireless efforts to raise funds to advance research.

With over 400,000 people living with dementia in Australia and approximately 55 million people worldwide, we have reached a point in history where advancing research is critical.

“Research is key to better understand these risk factors and how we can intervene to modify them and help delay dementia for future generations,” says PJ.

PJ says he continues to be inspired by the prospect that medical research can show early markers of memory decline so that brain disease can be detected before the onset of Alzheimer’s.

“It’s a privilege to work with the team at CHeBA. With the brilliant scientific minds of Henry Brodaty and Perminder Sachdev leading the way to research healthier brain ageing, it has been a wonderful relationship and a Centre I’m extremely proud to support.”

Donate to PJ at: https://sm23.grassrootz.com/cheba/pj-lane


About us:

The Centre for Healthy Brain Ageing (CHeBA) is a premier research institute at UNSW Sydney.

www.cheba.unsw.edu.a


Contact details:

Heidi Douglass h.douglass@unsw.edu.au

Media

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.